Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Ischemic Heart Disease

  Free Subscription


18.03.2024

1 Am Heart J
2 Am J Cardiol
1 Am J Med
3 Angiology
11 Atherosclerosis
1 BMJ
1 Cardiovasc Res
1 Circ Cardiovasc Imaging
1 Circ Cardiovasc Interv
3 Circ Res
6 Circulation
2 Clin Cardiol
1 Clin Chem
1 Eur Heart J
3 Heart
7 Int J Cardiol
3 J Am Coll Cardiol
2 J Clin Endocrinol Metab
1 J Electrocardiol
1 J Thorac Cardiovasc Surg
2 JAMA
1 N Engl J Med
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. KRUCOFF M, Spirito A, Baber U, Sartori S, et al
    Ticagrelor With or Without Aspirin Following Percutaneous Coronary Intervention in High-Risk Patients With Concomitant Peripheral Artery Disease: a subgroup analysis of the TWILIGHT randomized clinical trial.
    Am Heart J. 2024 Mar 6:S0002-8703(24)00053-X. doi: 10.1016/j.ahj.2024.
    PubMed         Abstract available


    Am J Cardiol

  2. DHALIWAL JS, Kumar N, Mactaggart S, Sakthivel H, et al
    Cardiovascular complications in young adults with Post-Acute Sequelae of COVID-19: a perspective from the United States.
    Am J Cardiol. 2024 Mar 11:S0002-9149(24)00164.
    PubMed        

  3. O'BRIEN JM, Dinh D, Roberts L, Teh A, et al
    Associations Between Metabolic Syndrome and Long-Term Mortality in Patients who underwent Percutaneous Coronary Intervention: An Australian Cohort Analysis.
    Am J Cardiol. 2024 Mar 4:S0002-9149(24)00146.
    PubMed         Abstract available


    Am J Med

  4. FREUND O, Shetrit A, Bar-Shai A, Zornitzki L, et al
    Smoking and respiratory diseases in patients with coronary microvascular dysfunction.
    Am J Med. 2024 Mar 12:S0002-9343(24)00134-7. doi: 10.1016/j.amjmed.2024.
    PubMed         Abstract available


    Angiology

  5. GIANNAKOPOULOU SP, Antonopoulos A, Panagiotakos D
    Serum Inflammatory Markers Used in Cardiovascular Disease Risk Prediction Models: A Systematic Review.
    Angiology. 2024 Mar 14:33197241239691. doi: 10.1177/00033197241239691.
    PubMed         Abstract available

  6. WANG K, Wang W, Niu J, Liu X, et al
    Elevated Plasma Lipoprotein(a) Level and Atherosclerotic Cardiovascular Disease Risks: A Large Clinical Retrospective Study.
    Angiology. 2024 Mar 13:33197241239688. doi: 10.1177/00033197241239688.
    PubMed         Abstract available

  7. JIAN W, Shen X, Zheng Z, Wu Z, et al
    Association Between Red Blood Cell Distribution Width and Coronary Calcification in Patients Referred for Invasive Coronary Angiography.
    Angiology. 2024 Mar 11:33197241238509. doi: 10.1177/00033197241238509.
    PubMed         Abstract available


    Atherosclerosis

  8. HAKAMAA E, Goebeler S, Martiskainen M, Louhelainen AM, et al
    Sex differences in coronary atherosclerosis during the pre- and postmenopausal period: The Tampere Sudden Death Study.
    Atherosclerosis. 2024;390:117459.
    PubMed         Abstract available

  9. GRINBERG T, Eisen A, Talmor-Barkan Y, Kornowski R, et al
    Novel plasma biomarkers of coronary artery calcium incidence or progression: Insights from the prospective multi-ethnic Dallas Heart Study cohort.
    Atherosclerosis. 2024;390:117469.
    PubMed         Abstract available

  10. SCHLEGEL A
    Diagnostic challenge of an APOB variant of uncertain significance resolved by transheterozygosity with a pathological LDLR variant and clinical response to therapy.
    Atherosclerosis. 2024;390:117460.
    PubMed        

  11. CHEDID G, Malik A, Daher R, Welty FK, et al
    Reply to: "Comments on "Higher exercise capacity, but not omega-3 fatty acid consumption, predicts lower coronary artery calcium scores in women and men with coronary artery disease"".
    Atherosclerosis. 2024;390:117452.
    PubMed        

  12. KHAN SU, Al-Mallah MH
    Air pollution and acute coronary syndrome: The air we breathe.
    Atherosclerosis. 2024;390:117453.
    PubMed        

  13. GU SZ, Ahmed ME, Huang Y, Hakim D, et al
    Comprehensive biomechanical and anatomical atherosclerotic plaque metrics predict major adverse cardiovascular events: A new tool for clinical decision making.
    Atherosclerosis. 2024;390:117449.
    PubMed         Abstract available

  14. FISHBEIN I, Inamdar VV, Alferiev IS, Bratinov G, et al
    Hypercholesterolemia exacerbates in-stent restenosis in rabbits: Studies of the mitigating effect of stent surface modification with a CD47-derived peptide.
    Atherosclerosis. 2023;390:117432.
    PubMed         Abstract available

  15. CENKO E, Manfrini O, Bugiardini R
    Net adverse clinical events with P2Y(12) inhibitor therapy in older patients after percutaneous coronary interventions.
    Atherosclerosis. 2024;390:117434.
    PubMed        

  16. ZHANG D, Li P, Qiu M, Liang Z, et al
    Net clinical benefit of clopidogrel versus ticagrelor in elderly patients carrying CYP2C19 loss-of-function variants with acute coronary syndrome after percutaneous coronary intervention.
    Atherosclerosis. 2023 Dec 13:117395. doi: 10.1016/j.atherosclerosis.2023.117395.
    PubMed         Abstract available

  17. ASMARIAN N, Raeisi Shahraki H
    Comments on "Higher exercise capacity, but not omega-3 fatty acid consumption, predicts lower coronary artery calcium scores in women and men with coronary artery disease".
    Atherosclerosis. 2024;390:117426.
    PubMed        

  18. RINALDI R, Russo M, Bonanni A, Camilli M, et al
    Short-term air pollution exposure and mechanisms of plaque instability in acute coronary syndromes: An optical coherence tomography study.
    Atherosclerosis. 2024;390:117393.
    PubMed         Abstract available


    BMJ

  19. TANNE JH
    Wegovy: FDA approves weight loss drug to cut cardiovascular risk.
    BMJ. 2024;384:q642.
    PubMed        


    Cardiovasc Res

  20. ABOULEISA RRE, Tang XL, Ou Q, Salama AM, et al
    Gene therapy encoding cell cycle factors to treat chronic ischemic heart failure in rats.
    Cardiovasc Res. 2024 Jan 4:cvae002. doi: 10.1093.
    PubMed         Abstract available


    Circ Cardiovasc Imaging

  21. BITTENCOURT MS
    Prognostic Value of Coronary Atherosclerotic Burden, Its Plaque Components and Estimation of Coronary Flow by Coronary Computed Tomography.
    Circ Cardiovasc Imaging. 2024 Mar 12:e016524.
    PubMed        


    Circ Cardiovasc Interv

  22. DAWSON LP, Rashid M, Dinh DT, Brennan A, et al
    No-Reflow Prediction in Acute Coronary Syndrome During Percutaneous Coronary Intervention: The NORPACS Risk Score.
    Circ Cardiovasc Interv. 2024 Mar 15:e013738.
    PubMed         Abstract available


    Circ Res

  23. LO EH, Faraci FM
    Circadian Mechanisms in Cardiovascular and Cerebrovascular Disease.
    Circ Res. 2024;134:615-617.
    PubMed        

  24. LAL H, Verma SK, Wang Y, Xie M, et al
    Circadian Rhythms in Cardiovascular Metabolism.
    Circ Res. 2024;134:635-658.
    PubMed         Abstract available

  25. ECKLE T, Bertazzo J, Khatua TN, Fatemi Tabatabaei SR, et al
    Circadian Influences on Myocardial Ischemia-Reperfusion Injury and Heart Failure.
    Circ Res. 2024;134:675-694.
    PubMed         Abstract available


    Circulation

  26. JUNCA G, Delgado V
    Dual (Ischemic and Nonischemic) Cardiomyopathy: A Wolf in Sheep's Clothing.
    Circulation. 2024;149:822-824.
    PubMed        

  27. HEUTS S, Myers PO, Siepe M
    Letter by Heuts et al Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
    Circulation. 2024;149:892-893.
    PubMed        

  28. RODRIGUEZ AE, Fernandez-Pereira C, Mieres J
    Letter by Rodriguez et al Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
    Circulation. 2024;149:894-895.
    PubMed        

  29. ZIMMERMANN FM, Ding VY, Fearon WF
    Response by Zimmermann et al to Letter Regarding Article, "Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial".
    Circulation. 2024;149:896.
    PubMed        

  30. HAYEK SS, Zaha VG, Bogle C, Deswal A, et al
    Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship: A Scientific Statement From the American Heart Association.
    Circulation. 2024 Mar 11. doi: 10.1161/CIR.0000000000001220.
    PubMed         Abstract available

  31. GABA P, Sabik JF, Murphy SA, Bellavia A, et al
    Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With or Without Diabetes: Findings From a Pooled Analysis of 4 Randomized Clinical Trials.
    Circulation. 2024 Mar 11. doi: 10.1161/CIRCULATIONAHA.123.065571.
    PubMed         Abstract available


    Clin Cardiol

  32. LIU L, Du X, Wei X, Dong W, et al
    The combination of high-frequency QRS and ST-segment alterations during exercise stress tests enhanced the diagnostic efficacy for coronary artery disease.
    Clin Cardiol. 2024;47:e24254.
    PubMed         Abstract available

  33. PAN Y, Wu TT, Deng CJ, Yang Y, et al
    Smoking and outcomes following personalized antiplatelet therapy in chronic coronary syndrome patients: A substudy from the randomized PATH-PCI trial.
    Clin Cardiol. 2024;47:e24214.
    PubMed         Abstract available


    Clin Chem

  34. DUGANI SB, Moorthy MV, Demler OV, Li C, et al
    Plasma Biomarker Profiles for Premature and Nonpremature Coronary Heart Disease in Women.
    Clin Chem. 2024 Mar 13:hvae007. doi: 10.1093.
    PubMed         Abstract available


    Eur Heart J

  35. VILAHUR G, Radike M, Sutelman P, Ben-Aicha S, et al
    Recombinant human soluble domain of CD39L3 and ticagrelor: cardioprotective effects in experimental myocardial infarction.
    Eur Heart J. 2024 Mar 15:ehae107. doi: 10.1093.
    PubMed         Abstract available


    Heart

  36. CASTELIJNS MC, Hageman SHJ, Teraa M, van der Meer MG, et al
    Generalisability of trials on antithrombotic treatment intensification in patients with cardiovascular disease.
    Heart. 2024;110:482-490.
    PubMed         Abstract available

  37. KITE TA, Ladwiniec A, Greenwood JP, Gale CP, et al
    Very early invasive strategy in higher risk non-ST-elevation acute coronary syndrome: the RAPID NSTEMI trial.
    Heart. 2023 Dec 16:heartjnl-2023-323513. doi: 10.1136/heartjnl-2023-323513.
    PubMed         Abstract available

  38. MYRMEL GMS, Steiro OT, Tjora HL, Langorgen J, et al
    Prognostic value of growth differentiation factor-15 3 months after an acute chest pain admission.
    Heart. 2024;110:508-516.
    PubMed         Abstract available


    Int J Cardiol

  39. MCCORD J
    Identification and definition of type 2 myocardial infarction: Where do we go from here?
    Int J Cardiol. 2024 Mar 7:131941. doi: 10.1016/j.ijcard.2024.131941.
    PubMed        

  40. DE ALENCAR NETO JN, Scheffer MK, Correia BP, Franchini KG, et al
    Systematic review and meta-analysis of diagnostic test accuracy of ST-segment elevation for acute coronary occlusion.
    Int J Cardiol. 2024;402:131889.
    PubMed         Abstract available

  41. OLSEN FJ, Smiseth OA, Biering-Sorensen T
    Improving post-MI risk stratification with pressure-strain loops: Work in progress.
    Int J Cardiol. 2024;402:131866.
    PubMed        

  42. DI VITO L, Di Giusto F, Grossi P
    Non-culprit plaque progression: What do we know?
    Int J Cardiol. 2024;402:131881.
    PubMed        

  43. GHIZZONI G, Leone AM, di Serafino L, Galante D, et al
    "The INOCA-IT: Rationale and design of a multicenter registry investigating ischemia in patients with non-obstructive coronary artery (INOCA) disease in Italy".
    Int J Cardiol. 2024;402:131859.
    PubMed         Abstract available

  44. BOERHOUT CKM, Vink CEM, Lee JM, de Waard GA, et al
    Impact of sex on the assessment of the microvascular resistance reserve.
    Int J Cardiol. 2024 Feb 3:131832. doi: 10.1016/j.ijcard.2024.131832.
    PubMed         Abstract available

  45. AL-YAFEAI Z, Sondhi M, Vadlamudi K, Vyas R, et al
    Novel anti-psoriasis agent-associated cardiotoxicity, analysis of the FDA adverse event reporting system (FAERS).
    Int J Cardiol. 2024;402:131819.
    PubMed         Abstract available


    J Am Coll Cardiol

  46. BRIGUORI C, Quintavalle C, Mariano E, D'Agostino A, et al
    Kidney Injury After Minimal Radiographic Contrast Administration in Patients With Acute Coronary Syndromes.
    J Am Coll Cardiol. 2024;83:1059-1069.
    PubMed         Abstract available

  47. KOSMIDOU I, Shahim B, Dressler O, Redfors B, et al
    Incidence, Predictors, and Impact of Hospital Readmission After Revascularization for Left Main Coronary Disease.
    J Am Coll Cardiol. 2024;83:1073-1081.
    PubMed         Abstract available

  48. BATCHELOR WB, Damluji AA
    Rehospitalization After PCI vs CABG for Left Main Disease: Refocusing Our Lens.
    J Am Coll Cardiol. 2024;83:1082-1084.
    PubMed        


    J Clin Endocrinol Metab

  49. COSTA FC, Gomes LG, de Lima TM, Bortolotto LA, et al
    Cardiovascular risk in women with nonclassical congenital adrenal hyperplasia.
    J Clin Endocrinol Metab. 2024 Mar 11:dgae155. doi: 10.1210.
    PubMed         Abstract available

  50. STOKAR J, Szalat A
    Cardiovascular Safety of Romosozumab vs. PTH Analogs for Osteoporosis Treatment: a Propensity Score Matched Cohort Study.
    J Clin Endocrinol Metab. 2024 Mar 14:dgae173. doi: 10.1210.
    PubMed         Abstract available


    J Electrocardiol

  51. BELLFIELD RAA, Ortega-Martorell S, Lip GYH, Oxborough D, et al
    Impact of ECG data format on the performance of machine learning models for the prediction of myocardial infarction.
    J Electrocardiol. 2024;84:17-26.
    PubMed         Abstract available


    J Thorac Cardiovasc Surg

  52. GAUDINO M, Bairey Merz CN, Sandner S, Creber RM, et al
    Randomized Comparison of the Outcome of Single Versus Multiple Arterial Grafts trial (ROMA):Women-a trial dedicated to women to improve coronary bypass outcomes.
    J Thorac Cardiovasc Surg. 2024;167:1316-1321.
    PubMed        


    JAMA

  53. KO D, Pascual-Leone A, Shah SJ
    Use of Lecanemab for Patients With Cardiovascular Disease: The Challenge of Uncertainty.
    JAMA. 2024 Mar 15. doi: 10.1001/jama.2024.2991.
    PubMed        

  54. ANDERER S
    Cannabis Use Linked to Elevated Myocardial Infarction and Stroke Risk.
    JAMA. 2024 Mar 15. doi: 10.1001/jama.2024.2075.
    PubMed        


    N Engl J Med

  55. ROSWELL RO, Wong MP, Stefanescu Schmidt AC, Petranovic M, et al
    Case 8-2024: A 55-Year-Old Man with Cardiac Arrest, Cardiogenic Shock, and Hypoxemia.
    N Engl J Med. 2024;390:1030-1043.
    PubMed        


    PLoS One

  56. ZUBERI S, Rafi H, Hussain A, Hashmi S, et al
    Upregulation of Nrf2 in myocardial infarction and ischemia-reperfusion injury of the heart.
    PLoS One. 2024;19:e0299503.
    PubMed         Abstract available

  57. SCHON C, Felismino A, de Sa J, Corte R, et al
    Correction: Efficacy of early cardiac rehabilitation after acute myocardial infarction: Randomized clinical trial protocol.
    PLoS One. 2024;19:e0300855.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.